Latest Pharma News Update... Aug 23
Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. ... Apr 23
NDO is a dysfunction of the bladder that results from congenital conditions... Mar 26
The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ... Jan 13
Amgen today announced that the U.S. Food and Drug Administration (FDA) has approved RIABNI™ (rituximab-arrx), a biosimilar to Rituxan® (rituximab)... Dec 18
Cipla receives US FDA approval for icatibant injectibles for angioedema... Jul 16
-Advertisements-